Ann: Preliminary results from SCENESSE adolescent EPP study, page-12

First 12 Last

Share
Profile

Follow
cuv101

899 Posts.

373

10/02/25

20:36

Post #: 77792429
Share

Originally posted by bedger: ↑

Too many investors on HC fixated on having too high a valuation on a poorly past managed company. That was then. This is now.

Another bio-tech stock where investors cannot see the wood (potential achievable commercial potential) for the trees (past share price falls due to over-exuberance amongst both investors and management ambition). This is a convincing result. Positive results in a confirmatory study supporting the extension of the SCENESSE label to adolescent EPP patients. This is positive news. Its is removal of a small risk (there might have been safety issues) to the expansion of use in Europe.

It met its safety study objectives (no major adverse events and drug tolerability). No better indication than "all eligible patients request further treatment under special access". Clearly the mild adverse symptoms seen, not dissimilar to past studies - I'd be curious to see these controlled for as possible general EPP symptoms in a wider future trial - were more than tolerable to the patients involved versus the benefits seen (not what the trial was about).

This is positive news, but thanks for your stock whoever sold me $11.32's. Oh no sorry I forgot, only shorters sell this stock.

Expand

“Too many investors on HC fixated on having too high a valuation on a poorly past managed company. That was then. This is now.”

it’s the exact same management!

I’ve been following Clinuvel since 2007, don’t worry about me. Incidentally the share price then was $11.50!

CUV Price at posting: $11.50 Sentiment: Sell Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

ASM

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

PH2

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

BBT

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $9.94		Change 0.130(1.33%)		Mkt cap ! $499.7M

Open	High	Low	Value	Volume
$9.90	$10.00	$9.82	$200.7K	20.25K

Buyers (Bids)

No.	Vol.	Price($)
6	364	$9.90

Sellers (Offers)

Price($)	Vol.	No.
$9.94	19	1

View Market Depth

No.	Vol.	Price($)
6	266	9.930
2	79	9.920
1	52	9.910
2	170	9.900
4	2792	9.890

Price($)	Vol.	No.
9.960	1607	8
9.970	54	1
9.980	159	4
9.990	418	3
10.000	1859	6

Last trade - 11.04am 17/06/2025 (20 minute delay)

CUV (ASX) Chart

Ann: Preliminary results from SCENESSE adolescent EPP study, page-12

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Preliminary results from SCENESSE adolescent EPP study, page-12

Top Stories

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News